Alpha Cognition Inc
ACOG
Rang în acțiuni
#19988
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Preț acțiune
$8.85
Capitalizare de piață
$137.45M
Schimbare (1 zi)
4.12%
Schimbare (1 an)
75.94%
Țară
US
Tranzacționează Alpha Cognition Inc (ACOG)
Categorie
Healthcare
Istoricul spliturilor pentru Alpha Cognition Inc (ACOG)
Acțiunea Alpha Cognition Inc (simbol: ACOG) a trecut printr-un total de 1 splituri.
Cel mai recent split a avut loc pe Nov 05, 2024.
O acțiune ACOG cumpărată înainte de Nov 05, 2024 este echivalentă astăzi cu 0.04 acțiuni ACOG.
Cel mai recent split a avut loc pe Nov 05, 2024.
O acțiune ACOG cumpărată înainte de Nov 05, 2024 este echivalentă astăzi cu 0.04 acțiuni ACOG.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| 2024-11-05 | 1:25 | x0.04 | x0.04 |
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
